Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

87.76
BATS BZX Real-Time Price
As of 12:10pm ET
 -1.22 / -1.37%
Today’s Change
55.00
Today|||52-Week Range
131.33
-19.08%
Year-to-Date
3 Buyout Targets That Could Get Snatched Up
Sep 21 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close88.98
Today’s open88.63
Day’s range86.99 - 88.64
Volume25,158
Average volume (3 months)1,145,363
Market cap$16.7B
Dividend yield--
Data as of 12:10pm ET, 09/26/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+476.82%
Earnings growth (next 5 years)+170.10%
Revenue growth (last year)+47.36%
P/E ratio231.3
Price/Sales26.95
Price/Book97.04

Competitors

 Today’s
change
Today’s
% change
BMRNBiomarin Pharmaceuti...-0.75-0.77%
PRGOPerrigo Company PLC-1.51-1.55%
MDVNMedivation Inc0.000.00%
VRTXVertex Pharmaceutica...-1.84-2.03%
Data as of 12:13pm ET, 09/26/2016

Financials

Next reporting dateOctober 27, 2016
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$753.8M
Annual profit (last year)$6.5M
Net profit margin0.87%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Hervé Hoppenot
Chief Financial Officer &
Executive Vice President
David W. Gryska
Corporate headquarters
Wilmington, Delaware

Forecasts

Search for Jobs